Inspire Veterinary Partners, INC DEF 14A proxy statements

Inspire Veterinary Partners, Inc. stockholders approved an amendment to increase authorized Class A Common Stock to 700 million shares.

Inspire Veterinary Partners, Inc. announces an increase in its authorized Class A Common Stock to 700 million shares, approved by majority stockholders via written consent.

Inspire Veterinary Partners, Inc. has filed definitive additional materials related to a proxy statement with the SEC.

Inspire Veterinary Partners, Inc. disclosed a 'going concern' warning from its former auditor and material weaknesses in internal controls, alongside routine annual meeting proposals.

Majority stockholders approved the issuance of common stock related to a $60 million private placement to accredited investors.

Inspire Veterinary Partners announces stockholder approval for a private placement involving the issuance of common stock and warrants.

Inspire Veterinary Partners' majority stockholders approved the potential issuance of shares underlying warrants from a March 2025 registered direct offering to comply with Nasdaq listing rules.

Inspire Veterinary Partners has increased its authorized Class A common stock shares to 100 million and ratified previous share issuances through written consent of majority stockholders, avoiding a formal meeting.

Inspire Veterinary Partners announces its 2024 Annual Meeting of Stockholders to be held on October 9, 2024, covering director elections and auditor ratification.

Inspire Veterinary Partners announces its 2024 Annual Meeting of Stockholders to be held on October 9, 2024, covering director elections and auditor ratification.

Inspire Veterinary Partners is increasing its authorized Class A Common Stock shares to 100 million following approval by majority stockholders.

Inspire Veterinary Partners' stockholders have approved the issuance of shares to Tumim Stone Capital LLC, potentially raising up to $30 million, to bolster working capital and for general corporate purposes.